Primecap Management’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.1M Sell
4,724,991
-2,800
-0.1% -$4.63K ﹤0.01% 271
2025
Q4
$10.4M Sell
4,727,791
-228,900
-5% -$430K 0.01% 256
2025
Q3
$8.03M Sell
4,956,691
-207,990
-4% -$435K 0.01% 266
2025
Q2
$13.4M Sell
5,164,681
-250,080
-5% -$986K 0.01% 256
2025
Q1
$36.4M Sell
5,414,761
-97,530
-2% -$691K 0.03% 203
2024
Q4
$37.4M Sell
5,512,291
-163,720
-3% -$1.08M 0.03% 206
2024
Q3
$47.1M Sell
5,676,011
-33,890
-0.6% -$245K 0.03% 190
2024
Q2
$36.2M Sell
5,709,901
-29,526
-0.5% -$227K 0.03% 202
2024
Q1
$53.2M Buy
5,739,427
+92,976
+2% +$1.09M 0.04% 187
2023
Q4
$72M Buy
5,646,451
+124,050
+2% +$1.29M 0.06% 161
2023
Q3
$57M Buy
5,522,401
+2,680
+0% +$31K 0.05% 168
2023
Q2
$72.4M Buy
5,519,721
+17,000
+0.3% +$208K 0.06% 160
2023
Q1
$61.5M Hold
5,502,721
0.05% 164
2022
Q4
$46.4M Buy
5,502,721
+69,970
+1% +$665K 0.04% 176
2022
Q3
$90.5M Buy
5,432,751
+35,130
+0.7% +$647K 0.09% 143
2022
Q2
$79.5M Sell
5,397,621
-48,370
-0.9% -$996K 0.07% 154
2022
Q1
$135M Buy
5,445,991
+502,100
+10% +$13M 0.1% 133
2021
Q4
$159M Buy
4,943,891
+1,970,200
+66% +$72M 0.11% 133
2021
Q3
$107M Buy
2,973,691
+1,014,348
+52% +$39.9M 0.08% 150
2021
Q2
$86.4M Buy
1,959,343
+767,343
+64% +$33.4M 0.06% 165
2021
Q1
$54.5M Buy
1,192,000
+459,500
+63% +$26.4M 0.04% 189
2020
Q4
$50.6M Buy
+732,500
New +$35.9M 0.04% 188

Other funds holding LUNG

Primecap Management's LUNG Position: Q1 2026 in Review

Primecap Management reduced its Pulmonx (LUNG) stake by 0.06% in Q1 2026, selling an estimated $4.63K and leaving 4,724,991 shares worth $6.1M. The position accounts for ﹤0.01% of the portfolio, ranked #271.

Primecap Management first reported a position in LUNG in Q4 2020 and has held it in 22 quarters since. The position peaked at $159M in Q4 2021. 113 funds tracked by Wall St. Rank hold LUNG as of Q1 2026.

  • Primecap Management held 4,724,991 shares of Pulmonx worth $6.1M as of Q1 2026.
  • Primecap Management sold 2,800 Pulmonx shares in Q1 2026, an estimated $4.63K.
  • Pulmonx made up ﹤0.01% of Primecap Management's portfolio in Q1 2026, its #271 holding.
  • Primecap Management first reported a position in Pulmonx in Q4 2020 and has held it in 22 quarters since.
  • Primecap Management's Pulmonx position peaked at $159M in Q4 2021.
  • 113 funds tracked by Wall St. Rank held Pulmonx as of Q1 2026.

Based on Primecap Management's 13F filing for Q1 2026, filed 11 May 2026.